Thomas Stauch
Overview
Explore the profile of Thomas Stauch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stolzel U, Jost L, Seehofer D, Egger-Heidrich K, Scheuermann U, Holig K, et al.
EJHaem
. 2025 Feb;
6(1):e21092.
PMID: 39967799
Introduction: Erythropoietic Protoporphyria (EPP) caused skin light sensitivity and liver cirrhosis in a 35-year-old patient who subsequently developed liver-failure. Methods: In absence of a human leukocyte antigens (HLA)-matched-unrelated donor, the...
2.
Kubisch I, Wohmann N, Wissniowski T, Stauch T, Oettel L, Diehl-Wiesenecker E, et al.
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597922
: Acute intermittent porphyria (AIP) is a metabolic disease characterised by neurovisceral crises with episodes of acute abdominal pain alongside life-altering, and often hidden, chronic symptoms. The elimination of precipitating...
3.
Gerischer L, Mainert M, Wohmann N, Kubisch I, Stolzel U, Stauch T, et al.
Healthcare (Basel)
. 2024 Jan;
12(1).
PMID: 38201016
Porphyrias, as most rare diseases, are characterized by complexity and scarcity of knowledge. A national registry in one of the largest European populations that prospectively collects longitudinal clinical and laboratory...
4.
Diehl-Wiesenecker E, Blaschke S, Wohmann N, Kubisch I, Stauch T, Mainert M, et al.
Orphanet J Rare Dis
. 2023 Jun;
18(1):146.
PMID: 37308920
Background: Acute porphyrias (APs) are a group of rare metabolic diseases related to a disturbed heme biosynthesis. Symptoms may first occur as life threatening attacks, comprising abdominal pain and/or variable...
5.
Matzdorff A, Alesci S, Gebhart J, Holzhauer S, Hutter-Kronke M, Kuhne T, et al.
Oncol Res Treat
. 2023 Feb;
46 Suppl 2:5-44.
PMID: 36787705
No abstract available.
6.
Brioli A, Gengenbach L, Mancuso K, Binder M, Ernst T, Heidel F, et al.
J Cancer Res Clin Oncol
. 2023 Feb;
149(9):6569-6574.
PMID: 36781500
Purpose: Outcomes of multiple myeloma (MM) patients who are refractory to daratumumab are dismal and no standard of treatment exists for this patients' population. Here, we investigate the role of...
7.
Matzdorff A, Alesci S, Gebhart J, Holzhauer S, Hutter-Kronke M, Kuhne T, et al.
Oncol Res Treat
. 2022 Dec;
46 Suppl 1:7-53.
PMID: 36572012
No abstract available.
8.
Haverkamp T, Bronisch O, Knosel T, Mogler C, Weichert W, Stauch T, et al.
J Cancer Res Clin Oncol
. 2022 Oct;
149(6):2647-2655.
PMID: 36245063
Introduction: Acute intermittent porphyria (AIP) is a very rare (orphan) metabolic disorder of porphyrin biosynthesis which is characterized by elevated plasma and urine levels of 5-aminolevulinic acid (5-ALA) and porphobilinogen...
9.
Vogeser M, Stauch T
MMW Fortschr Med
. 2022 Feb;
164(Suppl 4):6-8.
PMID: 35146707
No abstract available.
10.
Vogel J, Zomorodbakhsch B, Stauch T, Josfeld L, Hubner J
Eur J Cancer Care (Engl)
. 2021 Oct;
31(1):e13533.
PMID: 34708899
Objective: Cancer patients often use complementary and alternative medicine (CAM). The aim of this study was to assess the expectations of cancer patients towards their general practitioner (GP) regarding information...